Elevate-Derm Conference

Ata Moshiri, MD, MPH, FAAD, spoke about pathology interpretation and patient communication at Elevate-Derm Summer 2025, enhancing skin cancer diagnosis.

At Elevate-Derm Summer, Jim Treat, MD, outlined diagnostic limitations of imaging and the importance of recognizing capillary malformation patterns linked to other diseases.

Discover Walter Liszewski, MD's insights on emerging therapies and consumer safety at Elevate-Derm Summer 2025, focusing on allergy research and treatment advancements.

Catch up on coverage from the first day of the 2025 Elevate-Derm Summer Conference held in Park City, Utah.

Walter Liszewski, MD, highlights the clinical impact of patch testing and shares strategies for selecting and dosing JAK inhibitors at Elevate-Derm Summer.

Discover innovative research pearls at the Elevate-Derm Summer Conference 2025, focusing on psoriasis, skin cancer, and more.

New findings at Elevate Derm highlight remibrutinib's rapid and sustained efficacy in reducing chronic spontaneous urticaria symptoms, offering hope for patients.

Join Dermatology Times at the 2025 Elevate-Derm Summer Conference for expert insights and live updates from Park City, Utah.

Hawkes highlighted how second-generation TYK2 inhibitors improve upon earlier oral therapies with greater efficacy and selectivity.

Hawkes highlighted the intersection of oncology and dermatology, focusing on immune checkpoint inhibitors and their cutaneous adverse events.

Murase discussed safe dermatologic treatments during lactation, especially for chronic conditions needing biologics.

Murase identifies 4 main pregnancy dermatoses—atopic eruption, polymorphic eruption, extrahepatic cholestasis, and pemphigoid gestationis—as "baby bumps."

Catch up on coverage from the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

Catch up on coverage from the fourth and final day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

Discover top innovations, insights, and clinical pearls from Elevate-Derm in Scottsdale, where top insights for advanced practice providers took center stage.

At Elevate-Derm West, Murase shared promising results in treating severe itch with emerging therapies, offering hope for patients with few options.

Swanson shared practical tips from her Elevate-Derm West sessions, empowering clinicians with new strategies for pediatric skin care.

Murase noted small molecule treatments, like JAK inhibitors, remain unsafe for pregnant women.

Marghoob shares key dermoscopic features to help clinicians identify benign vs malignant lesions on various locations of the body.

Catch up on coverage from the third day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

The study demonstrated significant reductions in inflammatory and non-inflammatory lesions for Hispanic patients using CAB gel.

Chilukuri shared that 2 new sunscreen ingredients, physalis angulata and pycnogenol, can prevent heat-induced pigmentation, offering new options for patients.

Delgocitinib cream offers a safe, low-systemic-exposure option for chronic hand eczema, according to a poster from the Elevate-Derm conference.

Affordable at-home treatments, including microneedling and benzoyl peroxide, were top pearls at Chilukuri's Elevate-Derm session.

The TRACE study showed tralokinumab reduced genital AD severity and improved quality of life within 3 months of treatment.

Catch up on coverage from the second day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

From diet recommendations to biologic advancements, Jennifer Hsiao, MD, covered essential updates for treating patients with HS.

In a session at Elevate-Derm West, Cheever presented on the utilization of AI within dermatology to optimize patient communication and diversify research.

Expert tips from Whitney High, MD, at Elevate-Derm West 2024 guide experienced advanced practice providers in mastering dermatopathology and avoiding diagnostic pitfalls.

APPs found that patients on systemic therapies for AD experience fewer issues with adherence compared to those using topicals only.